The integration
of automated urine sediment and urine biochemical analysis in one system allows
rapid and easy urine analysis. At present, standalone automated urine sediment
analyzers help standardize sediment & biochemical analysis with minimum
operator interference and enable the rapid analysis of urine samples. Such
integrated systems have a huge potential in the automated devices market and can
help large hospitals and diagnostic labs to manage their workloads efficiently.
As a result, this area has been identified as an opportunity in the market.
The global albumin & creatinine tests market size is valued at an estimated USD 987 million in 2020 and
is projected to reach USD 2,103 million by 2025, at a CAGR of 16.3% during the
forecast period.
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156696568
Scope of the Report
This report categorizes the albumin & creatinine tests
market into the following segments and subsegments:
By Product
- Dipsticks
& Kits
- Analyzers
- Cartridges
- Cartridges
for POC Analyzers
- Cartridges
for Table-Top Analyzers
- Reagents
& Other Consumables
By Type
- Urine
Tests
- Urine
Albumin Tests
- Urine
Creatinine Tests
- Glycated
Albumin
- Blood
& Serum Creatinine Tests
By End User
- Hospitals
& Clinics’
- Diagnostic
Laboratories
- Research
Laboratories & Institutes
By Region
- North
America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Russia
- Rest
of Europe
- Asia
Pacific
- Japan
- China
- Australia
- South
Korea
- Rest
of Asia Pacific
- Latin
America
- Brazil
- Mexico
- Rest
of Latin America
- Middle
East & Africa
Market Segmentation:
Based on product, the albumin and creatinine tests
market is segmented into dipsticks & kits, analyzers, cartridges, and
reagents & other consumables. In 2019, the dipsticks & kits segment
accounted for the largest share in this market. The frequent purchase of these
products compared to instruments like analyzers and cartridges and the
increasing use of kit-based rapid techniques for albumin & creatinine tests
drive market growth.
Based on type, the albumin & creatinine tests
market is segmented into urine tests and blood & serum creatinine tests. In
2019, urine tests accounted for the largest share in this market. Factors such
as the rapid growth in the diagnostics segment and the increasing demand for
rapid and easy-to-use urine tests drive the growth of this segment.
Regional
Analysis: -
The global ACR Test Market is segmented into North America, Europe,
the Asia Pacific, Latin America,
and the Middle East and Africa.
In 2019, North America accounted
for the largest share in the global market. The large share of this regional
segment can primarily be attributed to the growth in demand for rapid urine
tests, increasing prevalence of chronic conditions leading to various kidney
diseases, rising government initiatives, and growing geriatric population.
Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=156696568
Top Key Players: -
The major players operating in this ACR Tests Market
are Thermo Fisher Scientific, Inc. (US), Roche Diagnostics (Switzerland),
PromoCell GmbH (Germany),
Abbott Laboratories (US), Siemens Healthineers (Germany),
Danaher Corporation (US), Sysmex Corporation (Japan),
Ortho Clinical Diagnostics (US), Randox Laboratories (UK), FUJIFILM Wako Pure
Chemical Corporation (Japan),
Abbexa Ltd. (UK), ACON Laboratories, Inc. (US), Arbor Assays Inc. (US), ARKRAY
Global Business Inc. (Japan),
Aviva Systems Biology (US), Axxora, LLC (UK), BioAssay Systems (US), Nova
Biomedical (US), Quantimetrix Corporation (US), RayBiotech Inc. (US), Sekisui
Diagnostics PEI Inc. (US), Teco Diagnostics (US), Tulip Diagnostics (India),
ulti med Products GmbH (Germany),
and URIT Medical Electronic Co., Ltd. (China).
No comments:
Post a Comment